Monotherapy with atazanavir as a simplification strategy: results from an observational study

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e101-3. doi: 10.1097/QAI.0b013e318258bf3c.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Atazanavir Sulfate
  • CD4 Lymphocyte Count
  • CD4-CD8 Ratio
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Humans
  • Male
  • Middle Aged
  • Oligopeptides / therapeutic use*
  • Pyridines / therapeutic use*
  • RNA, Viral / blood
  • Retrospective Studies
  • Treatment Failure

Substances

  • Anti-HIV Agents
  • Oligopeptides
  • Pyridines
  • RNA, Viral
  • Atazanavir Sulfate